These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26393889)

  • 21. pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents.
    Huang X; Yuan Y; Ruan W; Liu L; Liu M; Chen S; Zhou X
    J Nanobiotechnology; 2018 Mar; 16(1):30. PubMed ID: 29587764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mn(II)-containing coordination nanoparticles as highly efficient T(1) contrast agents for magnetic resonance imaging.
    Paul G; Prado Y; Dia N; Rivière E; Laurent S; Roch M; Elst LV; Muller RN; Sancey L; Perriat P; Tillement O; Mallah T; Catala L
    Chem Commun (Camb); 2014 Jun; 50(51):6740-3. PubMed ID: 24829060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.
    Hao Y; Wang L; Zhang B; Li D; Meng D; Shi J; Zhang H; Zhang Z; Zhang Y
    Int J Nanomedicine; 2016; 11():1759-78. PubMed ID: 27199556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective pH-Activated Theranostic Platform for Synchronous Magnetic Resonance Imaging Diagnosis and Chemotherapy.
    Wang D; Lin H; Zhang G; Si Y; Yang H; Bai G; Yang C; Zhong K; Cai D; Wu Z; Wang R; Zou D
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):31114-31123. PubMed ID: 30141893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
    Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
    Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple function nanocomposites of porous silica-CoFe
    Fan H; Xing X; Yang Y; Li B; Wang C; Qiu D
    Dalton Trans; 2017 Nov; 46(43):14831-14838. PubMed ID: 29043319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional Smart Yolk-Shell Nanostructure with Mesoporous MnO
    Zhuang H; Zhao M; Ding S; Liu L; Yuan W; Jiang L; Han X; Jiang L; Yi T
    ACS Appl Mater Interfaces; 2020 Sep; 12(35):38906-38917. PubMed ID: 32805820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEGylated magnetic Prussian blue nanoparticles asa multifunctional therapeutic agent for combined targeted photothermal ablation and pH-triggered chemotherapy of tumour cells.
    Xue P; Sun L; Li Q; Zhang L; Xu Z; Li CM; Kang Y
    J Colloid Interface Sci; 2018 Jan; 509():384-394. PubMed ID: 28923735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
    Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
    J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mn2+-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance.
    Zhu W; Liu K; Sun X; Wang X; Li Y; Cheng L; Liu Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(21):11575-82. PubMed ID: 25965554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer.
    Chen Y; Ye D; Wu M; Chen H; Zhang L; Shi J; Wang L
    Adv Mater; 2014 Nov; 26(41):7019-26. PubMed ID: 25156250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
    Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
    Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese-Based Layered Double Hydroxide Nanoparticles as a T
    Li B; Gu Z; Kurniawan N; Chen W; Xu ZP
    Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28585312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.